Tirzepatide, a recently approved medication, is capturing significant interest within the medical community as a likely game-changer for individuals diagnosed with Later-in-life Glucose Intolerance . Unlike traditional diabetes drugs , tirzepatide functions by targeting two pathways: GLP-1 and GIP, leading to better blood sugar levels and, in some